Health

Global Nuclear Medicine Radioisotope Markets 2021-2027: Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Others – Technetium-99m (Tc-99m) to Account for $24.8 Billion – ResearchAndMarkets.com

The report “Nuclear Medicine Radioisotopes – Global Market Trajectory & Analytics” was added to ResearchAndMarkets.com to offer.

Global market for nuclear medicine radioisotopes will reach a volume of 36.9 billion US dollars by 2027

In the midst of the COVID-19 crisis, the global nuclear medicine radioisotopes market, which is estimated to be US $ 17.1 billion in 2020, is expected to reach a revised size of US $ 36.9 billion by 2027 and will also reach a revised size of US $ 36.9 billion in the analysis period of 2020 a CAGR of 11.6% grow -2027.

Technetium-99M (Tc-99M), one of the segments analyzed in the report, is expected to have a CAGR of 12.3% and reach $ 24.8 billion by the end of the analysis period. After an early analysis of the business impact of the pandemic and its triggered economic crisis, growth in the Thallium-201 (Tl-201) segment will be adjusted to a revised CAGR of 10.6% for the next 7-year period.

The US market is valued at $ 5.1 billion, while China is forecast to grow by 11.1% CAGR

The US nuclear medicine radioisotope market is estimated at $ 5.1 billion in 2020. China, the second largest economy in the world, is expected to reach a market size of 6.4 billion US dollars by 2027, which corresponds to a CAGR of 11.1% more in the analysis period 2020 to 2027.

Other notable geographic markets include Japan and Canada, which will grow 10.3% and 9.7% respectively over the 2020-2027 period. Within Europe, growth of approx. 8.3% CAGR is forecast for Germany.

Iodine (I-123) segment recorded 11.3% CAGR record

In the global iodine segment (I-123), the United States, Canada, Japan, China, and Europe will drive the CAGR estimated for that segment of 11.1%. These regional markets, with a combined market size of $ 1.2 billion in 2020, are projected to reach a projected size of $ 2.5 billion by the end of the analysis period.

China will be one of the fastest growing in this cluster of regional markets. Led by countries like Australia, India and South Korea, the Asia-Pacific market is projected to reach $ 4.3 billion by 2027.

Key topics covered:

I. METHODOLOGY

II. SUMMARY

1. MARKET OVERVIEW

  • Insights into the influencer market

  • World market trajectories

  • Effects of Covid-19 and an impending global recession

2. FOCUS ON SELECTED PLAYERS (42 recommended players in total):

  • Bayer Healthcare AG

  • Bracco Imaging SpA

  • Cardinal Health, Inc.

  • GE Healthcare

  • Hologic, Inc.

  • Lantheus Medical Imaging, Inc.

  • Medtronic PLC

  • NTP radioisotopes SOC Ltd.

  • Positron Corporation

  • Siemens Healthineers

3. MARKET TRENDS & DRIVERS

4. PERSPECTIVE OF THE GLOBAL MARKET

  • Worldwide current and future analysis for nuclear medicine radioisotope by geographic region – USA, Canada, Japan, China, Europe, Asia-Pacific and other world markets – Independent analysis of annual sales in USD million for the years 2018 to 2027 and% CAGR

  • World Historic Review of Nuclear Medicine Radioisotopes by Geographic Region – United States, Canada, Japan, China, Europe, Asia Pacific, and Rest of the World – Independent Analysis of Annual Revenue in Million US Dollars for Years 2012-2017 and% CAGR

  • Global 15 Year Perspective for Nuclear Medicine Radioisotopes by Geographic Region – Percentage Breakdown of Value Sales for the United States, Canada, Japan, China, Europe, Asia Pacific, and the rest of the world for 2012, 2018, and 2027

  • Worldwide 15-Year Perspective for Technetium-99m (Tc-99m) by Geographic Region – Percentage breakdown of value sales for the US, Canada, Japan, China, Europe, the Asia-Pacific region and the rest of the world for the years 2012, 2018 and 2027

  • Worldwide 15-Year Perspective for Thallium-201 (Tl-201) by Geographic Region – Percentage breakdown of value sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of the World for the years 2012, 2018 & 2027

  • Worldwide 15 Year Perspective for Iodine (I-123) by Geographic Region – Percentage breakdown of value sales for the US, Canada, Japan, China, Europe, Asia Pacific and the rest of the world for 2012, 2018 and 2027

  • Worldwide 15-Year Perspective for Gallium-67 (Ga-67) by Geographic Region – Percentage breakdown of value sales for the USA, Canada, Japan, China, Europe, Asia-Pacific and the rest of the world for the years 2012, 2018 & 2027

  • Worldwide 15 Year Perspective for Other Types of Radioisotopes by Geographic Region – Percentage breakdown of value sales for the US, Canada, Japan, China, Europe, Asia Pacific and the rest of the world for 2012, 2018 and 2027

  • 15 Year Global Oncology Perspective by Geographic Region – Percentage Breakdown of Value Sales for the United States, Canada, Japan, China, Europe, Asia Pacific, and the rest of the world for 2012, 2018, and 2027

  • 15 Year Global Cardiology Perspective by Geographic Region – Percentage Breakdown of Value Sales for the United States, Canada, Japan, China, Europe, Asia Pacific, and the rest of the world for 2012, 2018, and 2027

  • Worldwide Lymphoma 15 Year Perspective by Geographic Region – Percentage Breakdown of Value Sales for the United States, Canada, Japan, China, Europe, Asia Pacific, and the rest of the world for 2012, 2018, and 2027

  • 15 Year Global Thyroid Perspective by Geographic Region – Percentage breakdown of value sales for the United States, Canada, Japan, China, Europe, Asia Pacific, and the rest of the world for 2012, 2018, and 2027

  • 15 Year Worldwide Neurology Perspective by Geographic Region – Percentage Breakdown of Value Sales for the United States, Canada, Japan, China, Europe, Asia Pacific, and Rest of the World for 2012, 2018, and 2027

III. MARKET ANALYSIS

IV. COMPETITION

Please visit https://www.researchandmarkets.com/r/df689t for more information on this report.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210531005232/en/

contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For EST office hours, call 1-917-300-0470
For US / CAN toll free call 1-800-526-8630
For GMT office hours, call + 353-1-416-8900. at

مقالات ذات صلة

اترك تعليقاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *

زر الذهاب إلى الأعلى